These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23153742)

  • 1. Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life.
    Militaru C; Donoiu I; Craciun A; Scorei ID; Bulearca AM; Scorei RI
    Nutrition; 2013 Jan; 29(1):178-83. PubMed ID: 23153742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Calcium Fructoborate on Levels of C-Reactive Protein, Total Cholesterol, Low-Density Lipoprotein, Triglycerides, IL-1β, IL-6, and MCP-1: a Double-blind, Placebo-controlled Clinical Study.
    Rogoveanu OC; Mogoşanu GD; Bejenaru C; Bejenaru LE; Croitoru O; Neamţu J; Pietrzkowski Z; Reyes-Izquierdo T; Biţă A; Scorei ID; Scorei RI
    Biol Trace Elem Res; 2015 Feb; 163(1-2):124-31. PubMed ID: 25433580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis.
    Scorei R; Mitrut P; Petrisor I; Scorei I
    Biol Trace Elem Res; 2011 Dec; 144(1-3):253-63. PubMed ID: 21607703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
    Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
    Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
    Bleske BE; Nicklas JM; Bard RL; Brook RD; Gurbel PA; Bliden KP; Rajagopalan S; Pitt B
    J Am Coll Cardiol; 2006 Jan; 47(2):338-41. PubMed ID: 16412857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium fructoborate--potential anti-inflammatory agent.
    Scorei RI; Rotaru P
    Biol Trace Elem Res; 2011 Dec; 143(3):1223-38. PubMed ID: 21274653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.
    Tomé-Carneiro J; Gonzálvez M; Larrosa M; Yáñez-Gascón MJ; García-Almagro FJ; Ruiz-Ros JA; García-Conesa MT; Tomás-Barberán FA; Espín JC
    Am J Cardiol; 2012 Aug; 110(3):356-63. PubMed ID: 22520621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary calcium fructoborate supplementation on joint comfort and flexibility and serum inflammatory markers in dogs with osteoarthritis.
    Price AK; de Godoy MRC; Harper TA; Knap KE; Joslyn S; Pietrzkowski Z; Cross BK; Detweiler KB; Swanson KS
    J Anim Sci; 2017 Jul; 95(7):2907-2916. PubMed ID: 28727103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
    Ogard CG; Engelmann MD; Kistorp C; Nielsen SL; Vestergaard H
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium fructoborate helps control inflammation associated with diminished bone health.
    Scorei ID; Scorei RI
    Biol Trace Elem Res; 2013 Dec; 155(3):315-21. PubMed ID: 23982445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial.
    Bischoff HA; Stähelin HB; Dick W; Akos R; Knecht M; Salis C; Nebiker M; Theiler R; Pfeifer M; Begerow B; Lew RA; Conzelmann M
    J Bone Miner Res; 2003 Feb; 18(2):343-51. PubMed ID: 12568412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
    Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial.
    Witham MD; Crighton LJ; Gillespie ND; Struthers AD; McMurdo ME
    Circ Heart Fail; 2010 Mar; 3(2):195-201. PubMed ID: 20103775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.
    Li JJ; Hu SS; Fang CH; Hui RT; Miao LF; Yang YJ; Gao RL
    Clin Chim Acta; 2005 Feb; 352(1-2):217-24. PubMed ID: 15653117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: a placebo controlled crossover trial.
    Chih S; Macdonald PS; McCrohon JA; Ma D; Moore J; Feneley MP; Law M; Kovacic JC; Graham RM
    Heart; 2012 Feb; 98(4):282-90. PubMed ID: 22115984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.